Clinical Trial Update: Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pressurized intraperitoneal aerosolized nab-paclitaxel in combination with gemcitabine and cisplatin for biliary tract cancers with per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Bile Duct Adenocarcinoma
• Gallbladder Cancer
• Intrahepatic Cholangiocarcinoma
• Peritoneal Metastasis

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma | Phase 1 | Status: RECRUITING